Welcome to Public Health On Call, a podcast from the Johns Hopkins Bloomberg School of Public Health,

where we bring evidence, experience, and perspective to make sense of today's leading health challenges.

If you have questions or ideas for us, please send an email to public health question at jhh.edu.

That's public health question at jhhu.edu for future podcast episodes.

Hi, I'm Sue Telecat from the Bloomberg American Health Initiative,

here to share more about the Bloomberg American Health Fellowship.

If you and your organization are working to reduce overdoses and violence,

improve food systems, protect the environment, or support adolescents in the United States,

you may be eligible for a full scholarship to earn an MPH or DRP degree at the Johns Hopkins

Bloomberg School of Public Health. From farmers to

firefighters to doctors to policymakers, the Bloomberg Fellowship can help you transform your

career, support your organization, and make a significant impact on your community.

Applications close on December 1st. Find out more at Americanhealth.j.j.u.edu backslash fellowship.

This is Lindsay Smith Rogers. In this episode, an update on vaccines. Dr. Bill Moss returns to the

podcast to talk about the big stories in vaccine-preventable diseases like measles and pertussis

in the U.S. and what's happening globally with

Mpox. We also discuss some exciting new vaccines in the pipeline. Let's listen. Bill Moss,

welcome back to the podcast. It's so good to have you again. How are you? Good. Thank you, Lindsay.

I'm very excited to speak with you again. Great. And today we are talking about all things vaccines, but we're going to start out first

with a big topic right now, and that is what's going on in the U.S. with these outbreaks of vaccine

preventable diseases. What are the big stories here?

Yeah. So I think the first thing is just to remind ourselves that here in the United States,

...